Speaker Profile
M.D., Ph.D., Founder and CEO, HelpTx
Biography
Eugene J. Wang, MD, PhD is the Founder and CEO of HELP Therapeutics Co. Ltd. (HelpTx), a pioneering regenerative medicine company he established in 2016.
A distinguished gold medalist during his college studies, Dr. Wang conducted his pivotal research at the First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital)—an institution consistently ranked among the top 20 hospitals in China. He earned his PhD from the University of Hong Kong and MD degree from Capital Medical University
Talk
A New Era in Heart Failure Treatment
A New Era in Heart Failure Treatment: Delivering on the Promise of iPSC-Derived Cardiomyocyte Therapy
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Catriona Jamieson, UCSD
Opening talk
• Catriona Jamieson, UCSD
PMWC Award Ceremony
• Judy Faulkner, Epic
• Alexis C. Komor, UCSD
What’s Next at Epic?
• Peter DeVault, Epic
RNA Therapeutics Beyond mRNA: siRNA, ASOs, and snRNA
• Chair: Alexis C. Komor, UCSD
• Niren Murthy, UC Berkeley
• Gene Yeo, UCSD
• Reuben Harris, UT Health San Antonio
Small Molecule Therapeutics Targeting Stem Cells
• Chair: Catriona Jamieson, UCSD
• Irving L. Weissman, Stanford
Space-Omics & Stem-Cell Adaptation
• Chair: Catriona Jamieson, UCSD
• Alysson Muotri, UCSD
In Vivo Gene Therapies
• Chair: Gene Yeo, UCSD
• Mark A Kay, Stanford
• David Schaffer, UC Berkeley
Diagnostics, Prognostics, and Patient Stratification
• Chair: Ezra Cohen, Tempus
• Gudrun Stengel, Alida Biosciences
• David Ledbetter, Florida State University
Bioprinting Transplantable Liver: mRNA-Driven Multi-Lineage Differentiation from Autologous iPSCs
• Jiwu Wang, The Scintillon Institute
A New Era in Heart Failure Treatment: Delivering on the Promise of iPSC-Derived Cardiomyocyte Therapy
• Eugene Wang, Help Therapeutics
Closing Talk
• Catriona Jamieson, UCSD
